ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO1286

Assessing Genomic Needs

Session Information

Category: Genetic Diseases of the Kidneys

  • 1002 Genetic Diseases of the Kidneys: Non-Cystic

Authors

  • Nestor, Jordan Gabriela, Columbia University, New York, New York, United States
  • Mohan, Sumit, Columbia University, New York, New York, United States
  • Gharavi, Ali G., Columbia University, New York, New York, United States
  • Weng, Chunhua, Columbia University, New York, New York, United States
Background

Interventions must address nephrologists’ knowledge gaps, perceived needs and willingness to utilize genomic data to guide more personalized patient care.

Methods

U.S. Boarded nephrologists were invited to complete an anonymous electronic needs assessment survey on genomic implementation that incorporated multiple themes e.g., objective knowledge, attitudes perceived barriers. Its design was informed by a comprehensive literature review and adapted published tools. Descriptive statistics were used to summarize demographics and baseline characteristics.

Results

Between January-May 2021, 319 complete surveys were eligible for analysis by nephrologists across 47 U.S. States, (86% adult vs. 14% pediatric), with 34% community-based (vs. 66% academic) including 36% who perform transplant evaluations and 75% with prior experience ordering genetic testing; 77% responded that genetic test results have meaningful implications for a patient’s care ≤ 50% of cases. Community nephrologists were more likely to cite limited experience, educational resources and access to experts as perceived barriers to implementation of genomics compared to those in academic practice.

Conclusion

Our findings highlight variable levels of experience and comfort using genomics and can inform the design of tailored interventions that address nephrologists’ specific needs, including education, workflow and clinical-decision support tools. Together, such tools can promote wider utilization of genomic resources and empower nephrologists to use genomic data.

Funding

  • Other NIH Support